Artiva Biotherapeutics, Inc. Common Stock (ARTV) Live Share Price, Invest From India

Artiva Biotherapeutics, Inc. Common Stock Stock Performance

as on May 27, 2026 at 6:59 am IST

Day's Low
Day's High
$7.60
Day's Price Range
$8.06
$7.66
0.78%
Downside
5.22%
Upside
52 Week's Low
52 Week's High
$1.47
52-Week Price Range
$14.53
$7.66
80.81%
Downside
89.69%
Upside

Artiva Biotherapeutics, Inc. Common Stock share price movements today

Previous Close: $7.87
Open: $8.00
Volume: 507.2K
Day's Low - High: $7.60 - $8.06
52 Week Low - High: $1.47 - $14.53

Artiva Biotherapeutics, Inc. Common Stock Historical Returns

1 Month Return: -23.74 %
3 Month Return: + 44.4 %
1 Year Return: + 303.59 %
3 Year Return: 0 %
5 Year Return: 0 %

Artiva Biotherapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Artiva Biotherapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$382.4M

EPS (TTM)

-2.5167

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-67.86%

Artiva Biotherapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Artiva Biotherapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Artiva Biotherapeutics, Inc. Common Stock	NA	$382.4M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.7B	114.3%	74.55	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$110.3B	110.12%	25.77	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$67.0B	28.51%	15.6	29.65%	0.5599999999999999%

Stock Returns calculator for Artiva Biotherapeutics, Inc. Common Stock Stock including INR - Dollar returns

The Artiva Biotherapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Artiva Biotherapeutics, Inc. Common Stock investment value today

Current value as on today

₹4,41,769

Returns

₹3,41,769

(+341.77%)

Returns from Artiva Biotherapeutics, Inc. Common Stock Stock

₹2,92,821 (+292.82%)

Dollar Impact

₹48,948 (+48.95%)

Indian Investors' Interest in Artiva Biotherapeutics, Inc. Common Stock Stock

Search interest for Artiva Biotherapeutics, Inc. Common Stock Stock has increased by 789% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 27, 2026 to May 27, 2026

Change:789% versus previous 30 day period

Artiva Biotherapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2	0	-	-	-	-	-	-	-	-
Gross Profit	2	0	-	-	-	-	-	0	0	0
Operating Income	-11	-14	-16	-18	-18	-22	-22	-22	-21	-24
EBITDA	-11	-13	-15	-17	-17	-21	-22	-22	-21	-23
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-13	-17	-17	-9	-20	-21	-21	-20	-23
Income Tax Expense	0	0	-1	-	-	-	-	-	-	-
Net Income	-11	-13	-17	-17	-9	-20	-21	-21	-20	-23
Net Profit Margin	-510.55%	-5562.95%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Artiva Biotherapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	2	4	33	0	-
Gross Profit	-	2	4	33	0	-2
Operating Income	-18	-53	-59	-30	-67	-90
EBITDA	-17	-71	-58	-28	-64	-88
Interest Expense	0	-	-	-	-	-
Depreciation	0	0	1	2	2	2
Income Before Tax	-17	-71	-58	-27	-58	-83
Income Tax Expense	0	-18	0	0	-	-
Net Income	-17	-71	-58	-27	-58	-83
Net Profit Margin	0.00%	-3587.66%	-1184.10%	-82.69%	-23303.98%	0.00%

Artiva Biotherapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-13	-17	-17	-16	-20	-21	-21	-20	-23
Operating Cash Flow	-15	-13	-11	-14	-19	-22	-19	-14	-20
Investing Cash Flow	9	1	-130	0	9	21	16	16	15
Financing Cash Flow	-	-1	163	0	0	0	0	0	0
Change in Cash	-5	-13	21	-15	-9	-1	-2	1	-5

Artiva Biotherapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-71	-58	-28	-65	-83
Operating Cash Flow	-15	-50	-47	-55	-76
Investing Cash Flow	-1	-6	-25	-120	63
Financing Cash Flow	152	-1	24	162	0
Change in Cash	135	-58	-49	-13	-13

Global Institutional Holdings in Artiva Biotherapeutics, Inc. Common Stock

Funds	Holdings
RA Capital Management, LLC	39.87%
Renaissance Technologies Corp	0.32%
Velan Capital Investment Management LP	0.1%
Wellington Management Company LLP	0.79%
Geode Capital Management, LLC	0.41%

See all

Insights on Artiva Biotherapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ARTV has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 1 month, ARTV stock has moved down by -26.8%

About Artiva Biotherapeutics, Inc. Common Stock

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. The company also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.

Organisation	Artiva Biotherapeutics, Inc. Common Stock
Headquarters	5505 Morehouse Drive, San Diego, CA, United States, 92121
Industry	Biotechnology
CEO	Dr. Fred Aslan M.D.
E-voting on shares	Click here to vote

Key Management of Artiva Biotherapeutics, Inc. Common Stock

Name	Title
Dr. David Moriarty Ph.D.	Senior VP of Clinical Operations
Dr. Fred Aslan M.D.	CEO, Principal Financial & Accounting Officer and Director
Dr. Gines Diego Miralles M.D.	President and Head of Research & Development
Ms. Jennifer Kinsbruner Bush Esq., J.D.	Chief Operating Officer
Dr. Nicholas Veomett Ph.D.	Vice President of Corporate Development
Dr. Heather Raymon Ph.D.	Senior Vice President of Research & Early Development
Mr. Christopher P. Horan	Chief Technical Operations Officer
Dr. Peter Flynn Ph.D.	Co-Founder & Strategic Advisor
Mr. Andrew Cronauer	VP, General Counsel & Corporate Secretary
Mr. Benjamin Dewees	Senior Vice President of Regulatory Affairs

FAQs

What is Artiva Biotherapeutics, Inc. Common Stock share price today?

Artiva Biotherapeutics, Inc. Common Stock share price today is $7.66 as on May 27, 2026 at 1:29 am IST at the close of the market. Artiva Biotherapeutics, Inc. Common Stock share today touched a day high of $8.06 and a low of $7.6.

What is the 52 week high and 52 week low for Artiva Biotherapeutics, Inc. Common Stock share?

Artiva Biotherapeutics, Inc. Common Stock share touched a 52 week high of $14.53 on April 20, 2026 and a 52 week low of $1.47 on June 27, 2025. Artiva Biotherapeutics, Inc. Common Stock stock price today i.e. May 27, 2026 at 1:29 am IST is closed at $7.66,which is 47.28% down from its 52 week high and 421.09% up from its 52 week low.

What is Artiva Biotherapeutics, Inc. Common Stock's market capitalisation today?

Artiva Biotherapeutics, Inc. Common Stock market capitalisation is $0.00T as on May 27, 2026 at 1:29 am IST.

How to invest in Artiva Biotherapeutics, Inc. Common Stock Stock (ARTV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Artiva Biotherapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Artiva Biotherapeutics, Inc. Common Stock Shares that will get you 0.1958 shares as per Artiva Biotherapeutics, Inc. Common Stock share price of $7.66 per share as on May 27, 2026 at 1:29 am IST.

What is the minimum amount required to buy Artiva Biotherapeutics, Inc. Common Stock Stock (ARTV) from India?

Indian investors can start investing in Artiva Biotherapeutics, Inc. Common Stock (ARTV) shares with as little as ₹95.69 or $1 (as of May 27, 2026 at 6:05 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.90 in Artiva Biotherapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on May 27, 2026 at 6:05 am IST). Based on Artiva Biotherapeutics, Inc. Common Stock share’s latest price of $7.66 as on May 27, 2026 at 1:29 am IST, you will get 1.3055 shares of Artiva Biotherapeutics, Inc. Common Stock. Learn more about fractional shares .